Laser immunotherapy for cutaneous squamous cell carcinoma with optimal thermal effects to enhance tumour immunogenicity

References

• Dotto GP, Rustgi AK. Squamous cell cancers: a unified perspective on biology and genetics. Cancer Cell. 2016;29:622–637.
   PubMed Web of Science ®Google Scholar
• Karia PS, Han J, Schmults CD. Cutaneous squamous cell carcinoma: estimated incidence of disease, nodal metastasis, and deaths from disease in the United States. J Am Acad Dermatol. 2013;68:957–966.
   PubMed Web of Science ®Google Scholar
• Wang X, Ji J, Zhang H, et al. Stimulation of dendritic cells by DAMPs in ALA-PDT treated SCC tumor cells. Oncotarget. 2015;6:44688–44702.
   PubMedGoogle Scholar
• Parikh SA, Patel VA, Ratner D. Advances in the management of cutaneous squamous cell carcinoma. F1000prime Reports. 2014;6:70.
   PubMedGoogle Scholar
• Hutchinson L. Skin cancer: setting the stage for cutaneous SCC. Nat Rev Clin Oncol. 2014;11:63.
   PubMedGoogle Scholar
• Mellman I, Coukos G, Dranoff G. Cancer immunotherapy comes of age. Nature. 2011;480:480–489.
   PubMed Web of Science ®Google Scholar
• Dey M, Chang AL, Miska J, et al. Dendritic cell-based vaccines that utilize myeloid rather than plasmacytoid cells offer a superior survival advantage in malignant glioma. JIImmunol. 2015;195:367–376.
   PubMed Web of Science ®Google Scholar
• Benci JL, Xu B, Qiu Y, et al. Tumor interferon signaling regulates a multigenic resistance program to immune checkpoint blockade. Cell. 2016;167:1540–54 e12.
   PubMed Web of Science ®Google Scholar
• Michele A, David HR. Cytokine therapy restores antitumor responses of NK cells rendered anergic in MHC I-deficient tumors. Oncoimmunology. 2015;5:e1002725.
   PubMed Web of Science ®Google Scholar
• Zindl CL, Chaplin DD. Immunology. Tumor immune evasion. Science. 2010;328:697–698.
   PubMed Web of Science ®Google Scholar
• Ruella M, Maus MV. Catch me if you can: leukemia escape after CD19-directed T cell immunotherapies. Comput Struct Biotechnol J. 2016;14:357–362.
   PubMed Web of Science ®Google Scholar
• Chen WR, Carubelli R, Liu H, et al. Laser immunotherapy: a novel treatment modality for metastatic tumors. Mol Biotechnol. 2003;25:37–44.
   PubMed Web of Science ®Google Scholar
• Chen WR, Liu H, Ritchey JW, et al. Effect of different components of laser immunotherapy in treatment of metastatic tumors in rats. Cancer Res. 2002;62:4295–4299.
   PubMed Web of Science ®Google Scholar
• Zhou F, Wu S, Song S, et al. Antitumor immunologically modified carbon nanotubes for photothermal therapy. Biomaterials. 2012;33:3235–3242.
   PubMed Web of Science ®Google Scholar
• Li X, Ferrel GL, Guerra MC, et al. Preliminary safety and efficacy results of laser immunotherapy for the treatment of metastatic breast cancer patients. Photochem Photobiol Sci. 2011;10:817–821.
   PubMed Web of Science ®Google Scholar
• Li X, Naylor MF, Le H, et al. Clinical effects of in situ photoimmunotherapy on late-stage melanoma patients: a preliminary study. Cancer Biol Ther. 2010;10:1081–1087.
   PubMed Web of Science ®Google Scholar
• Li M, Shi L, Luo M, et al. Successful treatment of Rosai–Dorfman disease using in situ photoimmunotherapy. Indian J Dermatol Venereol Leprol. 2017;83:332–336.
   PubMed Web of Science ®Google Scholar
• Chu KF, Dupuy DE. Thermal ablation of tumours: biological mechanisms and advances in therapy. Nat Rev Cancer. 2014;14:199–208.
   PubMed Web of Science ®Google Scholar
• Zhang HG, Mehta K, Cohen P, et al. Hyperthermia on immune regulation: a temperature's story. Cancer Lett. 2008;271:191–204.
   PubMed Web of Science ®Google Scholar
• Jenkins SV, Nedosekin DA, Miller EK, et al. Galectin-1-based tumour-targeting for gold nanostructure-mediated photothermal therapy. Int J Hyperthermia. 2018;34:19–29.
   PubMed Web of Science ®Google Scholar
• Liu S, Doughty A, West C, et al. Determination of temperature distribution in tissue for interstitial cancer photothermal therapy. Int J Hyperthermia. 2017;6:1–8.
   Google Scholar
• Guzhova IV1, Shevtsov MA, Abkin SV, et al. Intracellular and extracellular Hsp70 chaperone as a target for cancer therapy. Int J Hyperthermia. 2013;29:399–408.
   PubMed Web of Science ®Google Scholar
• den Brok MH, Sutmuller RP, van der Voort R, et al. In situ tumor ablation creates an antigen source for the generation of antitumor immunity. Cancer Res. 2004;64:4024–9.
   PubMed Web of Science ®Google Scholar
• Frey B, Weiss EM, Rubner Y, et al. Old and new facts about hyperthermia-induced modulations of the immune system. Int J Hyperthermia. 2012;28:528–542.
   PubMed Web of Science ®Google Scholar
• Werthmöller N, Frey B, Rückert M, et al. Combination of ionising radiation with hyperthermia increases the immunogenic potential of B16-F10 melanoma cells in vitro and in vivo. Int J Hyperthermia. 2016;32:23–30.
   PubMed Web of Science ®Google Scholar
• Schmidtner J, Distel LV, Ott OJ, et al. Hyperthermia and irradiation of head and neck squamous cancer cells causes migratory profile changes of tumour infiltrating lymphocytes. Int J Hyperthermia. 2009;25:347–354.
   PubMed Web of Science ®Google Scholar
• Repasky EA, Evans SS, Dewhirst MW. Temperature matters! And why it should matter to tumor immunologists. Cancer Immunol Res. 2013;1:210–216.
   PubMed Web of Science ®Google Scholar
• Evans SS, Repasky EA, Fisher DT. Fever and the thermal regulation of immunity: the immune system feels the heat. Nat Rev Immunol. 2015;15:335–349.
   PubMed Web of Science ®Google Scholar
• Meinander A, Soderstrom TS, Kaunisto A, et al. Fever-like hyperthermia controls T Lymphocyte persistence by inducing degradation of cellular FLIPshort. J Immunol. 2007;178:3944–3953.
   PubMed Web of Science ®Google Scholar
• Hanna E, Abadi R, Abbas O. Imiquimod in dermatology: an overview. Int J Dermatol. 2007;55:831–844.
   Web of Science ®Google Scholar
• Martín-García RF. Imiquimod: an effective alternative for the treatment of invasive cutaneous squamous cell carcinoma. Dermatol Surg. 2005;31:371–374.
   PubMed Web of Science ®Google Scholar
• Tillman DK Jr, Carroll MT. Topical imiquimod therapy for basal and squamous cell carcinomas: a clinical experience. Cutis. 2007;79:241–248.
   PubMed Web of Science ®Google Scholar
• Tiodorovic-Zivkovic D, Zalaudek I, Longo C, et al. Successful treatment of two invasive squamous cell carcinomas with topical 5% imiquimod cream in elderly patients. Eur J Dermatol. 2012;22:579–580.
   PubMed Web of Science ®Google Scholar
• Wang H, Li J, Lv T, et al. Therapeutic and immune effects of 5-aminolevulinic acid photodynamic therapy on UVB-induced squamous cell carcinomas in hairless mice. Exp Dermatol. 2013;22:362–363.
   PubMed Web of Science ®Google Scholar
• Chen WR, Adams RL, Carubelli R, et al. Laser-photosensitizer assisted immunotherapy: a novel modality for cancer treatment. Cancer Lett. 1997;115:25–30.
   PubMed Web of Science ®Google Scholar
• Ratushny V, Gober MD, Hick R, et al. From keratinocyte to cancer: the pathogenesis and modeling of cutaneous squamous cell carcinoma. J Clin Invest. 2012;122:464–472.
   PubMed Web of Science ®Google Scholar
• Thompson AK, Kelley BF, Prokop LJ, et al. Risk factors for cutaneous squamous cell carcinoma recurrence, metastasis, and disease-specific death: a systematic review and meta-analysis. JAMA Dermatol. 2016;152:419–428.
   PubMed Web of Science ®Google Scholar
• Manyam BV, Gastman B, Zhang AY, et al. Inferior outcomes in immunosuppressed patients with high-risk cutaneous squamous cell carcinoma of the head and neck treated with surgery and radiation therapy. J Am Acad Dermatol. 2015;73:221–227.
   PubMed Web of Science ®Google Scholar
• Barlow BR, Marshall RV, Wofford JD. Giant cutaneous squamous cell carcinoma requiring emergent embolization. JAAD Case Rep. 2016;2:216–218.
   PubMedGoogle Scholar
• Burton KA, Ashack KA, Khachemoune A. Cutaneous squamous cell carcinoma: a review of high-risk and metastatic disease. Am J Clin Dermatol. 2016;17:491–508.
   PubMed Web of Science ®Google Scholar
• Andocs G, Meggyeshazi N, Balogh L, et al. Upregulation of heat shock proteins and the promotion of damage-associated molecular pattern signals in a colorectal cancer model by modulated electrohyperthermia. Cell Stress Chaperones. 2015;20:37–46.
   PubMed Web of Science ®Google Scholar
• Kobayashi T, Kakimi K, Nakayama E, et al. Antitumor immunity by magnetic nanoparticle-mediated hyperthermia. Nanomedicine (Lond). 2014;9:1715–1726.
   PubMed Web of Science ®Google Scholar
• Vandenabeele P, Vandecasteele K, Bachert C, et al. Immunogenic apoptotic cell death and anticancer immunity. Adv Exp Med Biol. 2016;930:133–149.
   PubMed Web of Science ®Google Scholar
• Garg AD, Nowis D, Golab J, et al. Immunogenic cell death, DAMPs and anticancer therapeutics: an emerging amalgamation. Biochim Biophys Acta. 2010;1805:53–71.
   PubMed Web of Science ®Google Scholar
• Zitvogel L, Kepp O, Kroemer G. Decoding cell death signals in inflammation and immunity. Cell. 2010;140:798–804.
   PubMed Web of Science ®Google Scholar
• Palm NW, Medzhitov R. Pattern recognition receptors and control of adaptive immunity. Immunol Rev. 2009;227:221–233.
   PubMed Web of Science ®Google Scholar
• Krysko DV, Garg AD, Kaczmarek A, et al. Immunogenic cell death and DAMPs in cancer therapy. Nat Rev Cancer. 2012;12:860–875.
   PubMed Web of Science ®Google Scholar
• D'Eliseo D, Manzi L, Velotti F. Capsaicin as an inducer of damage-associated molecular patterns (DAMPs) of immunogenic cell death (ICD) in human bladder cancer cells. Cell Stress Chaperones. 2013;18:801–808.
   PubMed Web of Science ®Google Scholar
• Krysko O, Løve Aaes T, Bachert C, et al. Many faces of DAMPs in cancer therapy. Cell Death Dis. 2013;4:e631.
   PubMed Web of Science ®Google Scholar
• Sangiuliano B, Perez NM, Moreira DF, et al. Cell death-associated molecular-pattern molecules: inflammatory signaling and control. Mediators Inflamm. 2014;2014:821043.
   PubMed Web of Science ®Google Scholar
• Binder RJ. Functions of heat shock proteins in pathways of the innate and adaptive immune system. J Immunol. 2014;193:5765–5771.
   PubMed Web of Science ®Google Scholar
• Rozenberg P, Kocsis J, Saar M, et al. Elevated levels of mitochondrial mortalin and cytosolic HSP70 in blood as risk factors in patients with colorectal cancer. Int J Cancer. 2013;133:514–518.
   PubMed Web of Science ®Google Scholar
• Soudry E, Stern Shavit S, Hardy B, et al. Heat shock proteins HSP90, HSP70 and GRP78 expression in medullary thyroid carcinoma. Ann Diagn Pathol. 2017;26:52–56.
   PubMed Web of Science ®Google Scholar
• Tesniere A, Panaretakis T, Kepp O, et al. Molecular characteristics of immunogenic cancer cell death. Cell Death Differ. 2008;15:3–12.
   PubMed Web of Science ®Google Scholar
• Spisek R, Dhodapkar MV. Towards a better way to die with chemotherapy: role of heat shock protein exposure on dying tumor cells. Cell Cycle. 2007;6:1962–1965.
   PubMed Web of Science ®Google Scholar
• Zhou YJ, Binder RJ. The heat shock protein-CD91 pathway mediates tumor immunosurveillance. Oncoimmunology. 2014;3:e28222.
   PubMed Web of Science ®Google Scholar
• Horváth I, Vígh L. Cell biology: stability in times of stress. Nature. 2010;463:436–438.
   PubMed Web of Science ®Google Scholar
• Schildkopf P, Frey B, Mantel F, et al. Application of hyperthermia in addition to ionizing irradiation fosters necrotic cell death and HMGB1 release of colorectal tumor cells. Biochem Biophys Res Commun. 2010;391:1014–1020.
   PubMed Web of Science ®Google Scholar
• Ko YB, Kim BR, Nam SL, et al. High-mobility group box 1 (HMGB1) protein regulates tumor-associated cell migration through the interaction with BTB domain. Cell Signal. 2014;26:777–783.
   PubMed Web of Science ®Google Scholar
• Schön M, Bong AB, Drewniok C, et al. Tumor-selective induction of apoptosis and the small-molecule immune response modifier imiquimod. J Natl Cancer Inst. 2003;95:1138–1149.
   PubMed Web of Science ®Google Scholar
• Sohn KC, Li ZJ, Choi DK, et al. Imiquimod induces apoptosis of squamous cell carcinoma (SCC) cells via regulation of A20. PLoS One. 2014;9:e95337.
   PubMed Web of Science ®Google Scholar
• Knatko EV, Praslicka B, Higgins M, et al. Whole-exome sequencing validates a preclinical mouse model for the prevention and treatment of cutaneous squamous cell carcinoma. Cancer Prev Res. 2017;10:67–75.
   PubMed Web of Science ®Google Scholar
• Dickerson EB, Dreaden EC, Huang X, et al. Gold nanorod assisted near-infrared plasmonic photothermal therapy (PPTT) of squamous cell carcinoma in mice. Cancer Lett. 2008;269:57–66.
   PubMed Web of Science ®Google Scholar
• Zhou F, Li X, Naylor MF, et al. InCVAX–a novel strategy for treatment of late-stage, metastatic cancers through photoimmunotherapy induced tumor-specific immunity. Cancer Lett. 2015;359:169–177.
   PubMed Web of Science ®Google Scholar